Medical Research
(H113)
IRS Verified
DX Registered
CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$39.1M
Total Revenue
$33.6M
Total Expenses
N/A
Net Assets
0
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $39.1M | $33.6M | N/A | — | 0 |
| 2022 | $33.1M | $32.9M | N/A | — | 0 |
| 2021 | $24.6M | $28.4M | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.